CYTOTIL
DEAD

Serial Number

88667528

Owner

Obsidian Therapeutics, Inc.

Attorney

Olivia Maria Baratta

Filing Date

Oct 24, 2019

Add to watchlist:

No watchlists yet
View on USPTO

CYTOTIL Trademark

Serial Number: 88667528

CYTOTIL is a trademark filed by Obsidian Therapeutics, Inc. on October 24, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Obsidian Therapeutics, Inc. (24 trademarks)

1030 Massachusetts Avenue, Fourth Floor
Cambridge, MA 02138

Entity Type: 03

Trademark Details

Filing Date

October 24, 2019

Registration Date

Not Registered

Published for Opposition

March 24, 2020

Goods & Services

Custom manufacture of cells for medical or clinical use for others; Custom manufacture of pharmaceutical preparations for others in the fields of cell therapy, gene therapy, regenerative medicine and biopharmaceuticals; Custom manufacture of biological preparations for others for the treatment of cancer

Cells for medical or clinical use; Pharmaceutical preparations in the fields of cell therapy, gene therapy, oncology, and immunotherapy for the prevention and treatment of cancer, cardio-vascular system disorders, genitourinary system disorders, immune system disorders, metabolic system disorders, musculo-skeletal system disorders, nervous system disorders, respiratory system disorders, inflammatory disorders, and gastroenterological disorders; Biological preparations for the treatment of cancer

Cells for scientific, laboratory or medical research

Medical and scientific research and development services in the fields of cell therapy, gene therapy, oncology, and immunotherapy

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 20, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 19, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 12, 2023 EXRA
SOU EXTENSION 5 GRANTED
Jan 11, 2023 EX5G
NOTICE OF REVIVAL - E-MAILED
Dec 28, 2022 NREV
SOU EXTENSION RECEIVED WITH TEAS PETITION
Dec 28, 2022 TPEX
PETITION TO REVIVE-GRANTED
Dec 28, 2022 PETG
TEAS PETITION TO REVIVE RECEIVED
Dec 28, 2022 PROA
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Dec 27, 2022 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 26, 2022 ABN6
SOU EXTENSION 5 FILED
Nov 21, 2022 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 11, 2022 EXRA
SOU EXTENSION 4 GRANTED
May 9, 2022 EX4G
SOU EXTENSION 4 FILED
May 9, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
May 9, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 30, 2021 EXRA
SOU EXTENSION 3 GRANTED
Nov 29, 2021 EX3G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 29, 2021 AITU
SOU EXTENSION 3 FILED
Nov 19, 2021 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 19, 2021 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 18, 2021 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 18, 2021 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 18, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 18, 2021 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 6, 2021 EXRA
SOU EXTENSION 2 GRANTED
May 4, 2021 EX2G
SOU EXTENSION 2 FILED
May 4, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
May 4, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 7, 2020 EXRA
SOU EXTENSION 1 GRANTED
Nov 5, 2020 EX1G
SOU EXTENSION 1 FILED
Nov 5, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 5, 2020 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 19, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 24, 2020 NPUB
PUBLISHED FOR OPPOSITION
Mar 24, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 4, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 17, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 3, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 3, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 3, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 3, 2020 CNEA
ASSIGNED TO EXAMINER
Jan 30, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 30, 2019 NWOS
NEW APPLICATION ENTERED
Oct 28, 2019 NWAP